Xuefeng Liu
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 2%
- Epidemiology top 5%
- Co-authors
- Richard SchlegelHang YuanAleksandra DakicHanyujie KangZhaohui TongYishan WangSandra ChapmanAlison A. McBride
- Topics
- Epigenetics and DNA Methylation (18 papers)Bladder and Urothelial Cancer Treatments (14 papers)Cancer Cells and Metastasis (13 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Xuefeng Liu
184 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Molecular Biology 2.8k
- Oncology 1.1k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 1.0k
- Epidemiology 918
Countries citing papers authored by Xuefeng Liu
This map shows the geographic impact of Xuefeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Liu more than expected).
Fields of papers citing papers by Xuefeng Liu
This network shows the impact of papers produced by Xuefeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Liu. The network helps show where Xuefeng Liu may publish in the future.
Co-authorship network of co-authors of Xuefeng Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Liu. A scholar is included among the top collaborators of Xuefeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Liu. Xuefeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 0 | |
| 10 | 10 | |
| 11 | 7 | |
| 12 | 8 | |
| 13 | 10 | |
| 14 | 22 | |
| 15 | 21 | |
| 16 | 13 | |
| 17 | 32 | |
| 18 | 105 | |
| 19 | 2 | |
| 20 | 10 |
About Xuefeng Liu
Xuefeng Liu is a scholar working on Business and International Management, Cancer Research and Oncology, having authored 192 papers that have together received 6.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (18 papers), Bladder and Urothelial Cancer Treatments (14 papers) and Cancer Cells and Metastasis (13 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.1k citations) and Molecular Biology (2.8k citations). Xuefeng Liu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Richard Schlegel, Hang Yuan, Aleksandra Dakic, Hanyujie Kang, Zhaohui Tong, Yishan Wang, Sandra Chapman, Alison A. McBride, Xinghuan Wang and Yu Xiao. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.